Precipio reports $4.4m for q2-2024 (unaudited) revenues, a leap of 30% from q1-2024

Pathology revenues in june exceed breakeven target and continue growth trend pathology revenues in june exceed breakeven target and continue growth trend

PRPO Ratings Summary

PRPO Quant Ranking